Ken Griffin Illumina, Inc. Transaction History

Citadel Advisors LLC

$483 Billion
Q2 2024

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Illumina, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 174,700 shares of ILMN stock, worth $22.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

174,700

Previous 169,300 3.19%

Holding current value

$22.9 Million

Previous $23.2 Million 21.56%

% of portfolio

0.0%

Previous 0.0%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$101.05 - $133.57 $71.5 Million - $94.4 Million	-707,086 Reduced 62.39%	426,303 $44.5 Million
Q1 2024 May 15, 2024	BUY	$127.73 - $147.2 $90.3 Million - $104 Million	706,736 Added 165.65%	1,133,389 $156 Million
Q4 2023 Feb 14, 2024	SELL	$92.79 - $142.53 $81.8 Million - $126 Million	-881,950 Reduced 67.4%	426,653 $59.4 Million
Q3 2023 Nov 14, 2023	BUY	$128.91 - $192.44 $105 Million - $157 Million	818,304 Added 166.9%	1,308,603 $180 Million
Q2 2023 Aug 14, 2023	SELL	$183.43 - $232.67 $98 Million - $124 Million	-534,260 Reduced 52.15%	490,299 $91.9 Million
Q1 2023 May 15, 2023	SELL	$193.75 - $232.55 $68.7 Million - $82.4 Million	-354,488 Reduced 25.71%	1,024,559 $238 Million
Q4 2022 Feb 14, 2023	BUY	$187.24 - $242.74 $15.6 Million - $20.3 Million	83,444 Added 6.44%	1,379,047 $279 Million
Q3 2022 Nov 14, 2022	BUY	$177.23 - $227.44 $22.9 Million - $29.4 Million	129,105 Added 11.07%	1,295,603 $247 Million
Q2 2022 Aug 15, 2022	BUY	$181.58 - $368.0 $66.8 Million - $135 Million	368,055 Added 46.1%	1,166,498 $215 Million
Q1 2022 May 16, 2022	BUY	$303.87 - $423.8 $28.3 Million - $39.5 Million	93,287 Added 13.23%	798,443 $279 Million
Q4 2021 Feb 14, 2022	BUY	$347.28 - $421.83 $175 Million - $212 Million	503,649 Added 249.94%	705,156 $268 Million
Q3 2021 Nov 15, 2021	BUY	$405.61 - $524.84 $42.6 Million - $55.2 Million	105,126 Added 109.07%	201,507 $81.7 Million
Q2 2021 Aug 16, 2021	SELL	$372.84 - $481.5 $57.8 Million - $74.7 Million	-155,037 Reduced 61.67%	96,381 $45.6 Million
Q1 2021 May 17, 2021	BUY	$361.28 - $504.76 $25.1 Million - $35.1 Million	69,512 Added 38.21%	251,418 $96.6 Million
Q4 2020 Feb 16, 2021	BUY	$292.7 - $370.96 $3.52 Million - $4.46 Million	12,013 Added 7.07%	181,906 $67.3 Million
Q3 2020 Nov 16, 2020	BUY	$268.51 - $400.74 $38.1 Million - $56.8 Million	141,763 Added 503.96%	169,893 $52.5 Million
Q2 2020 Aug 14, 2020	SELL	$256.46 - $373.01 $5.58 Million - $8.11 Million	-21,742 Reduced 43.6%	28,130 $10.4 Million
Q1 2020 May 15, 2020	SELL	$209.2 - $335.53 $13 Million - $20.9 Million	-62,354 Reduced 55.56%	49,872 $13.6 Million
Q4 2019 Feb 14, 2020	SELL	$288.29 - $335.49 $138 Million - $161 Million	-479,586 Reduced 81.04%	112,226 $37.2 Million
Q3 2019 Nov 14, 2019	BUY	$266.84 - $378.23 $71.2 Million - $101 Million	266,693 Added 82.03%	591,812 $180 Million
Q2 2019 Aug 14, 2019	BUY	$300.59 - $368.15 $85.7 Million - $105 Million	285,180 Added 714.04%	325,119 $120 Million
Q1 2019 May 15, 2019	SELL	$272.57 - $321.18 $6.59 Million - $7.76 Million	-24,173 Reduced 37.7%	39,939 $0
Q4 2018 Feb 14, 2019	SELL	$272.46 - $366.54 $51.6 Million - $69.4 Million	-189,344 Reduced 74.7%	64,112 $19.2 Million
Q3 2018 Nov 13, 2018	BUY	$279.04 - $367.06 $7.32 Million - $9.63 Million	26,245 Added 11.55%	253,456 $0
Q2 2018 Aug 10, 2018	BUY	$228.17 - $292.07 $33.2 Million - $42.5 Million	145,469 Added 177.96%	227,211 $0
Q1 2018 May 11, 2018	BUY	$209.54 - $253.91 $874,619 - $1.06 Million	4,174 Added 5.38%	81,742 $19.3 Million
Q4 2017 Feb 09, 2018	SELL	$202.23 - $230.03 $52.2 Million - $59.3 Million	-257,965 Reduced 76.88%	77,568 $16.9 Million
Q3 2017 Nov 09, 2017	BUY	$172.3 - $213.93 $57.8 Million - $71.8 Million	335,533	335,533 $66.8 Million

Others Institutions Holding ILMN

# of Institutions

852

Shares Held

138M

Call Options Held

1.41M

Put Options Held

1.66M

View Full List

About ILLUMINA, INC.

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $20.6B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

More about ILMN

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account